Delays in clinical trials often hide in late supply planning. Early integration of supply strategy ensures product availability, reduces risk, and keeps studies on schedule.
- What's Breaking In Clinical Trial Supply — And How To Fix It
- R&D Capitalization Decisions That Drive Clinical Trial Supply
- The RTSM–EDC Integration Trap: Why Broken Workflows Still Undermine Trial Execution
- Building Win-Win Partnerships In Clinical Trial Supply
- The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early
- Bridging Preclinical Science And Trial Supply Success
- The New Reality Of Clinical Trial Logistics
- Drug Shortages In Clinical Trials: A Policy Blueprint
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Streamlining Clinical Supply With Advanced Automation
Clinical trials are the backbone of pharmaceutical advancements, but they come with their own set of challenges, particularly in data management and supply chain logistics.
-
Navigating Audit Trail Data Regulations And Accessibility Changes
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology
Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.
-
Treating Deficiencies In Employee Training And Mentorship
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
-
Optimizing IRT For Clinical Supply Management
Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.
-
Transforming The Pharma Supply Chain
Start leveraging logistics partners with global end-to-end solutions that can help avoid costly delays, ensure high product quality, and accelerate impactful solutions for patients worldwide.
-
Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch
Tech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.
-
Practical Playbook For The Manual Assembly Of Combination Products
Manual assembly plays a vital role in early‑phase combination product development. Learn how strong process design, collaboration, and quality controls help teams reduce risk, improve consistency, and move confidently toward later‑stage manufacturing.
-
Using IRT Data To Automate And Optimize Clinical Supply
Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial
Evaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.